Medical Instruments & Supplies M&A » By The Online Investor Staff, updated Tue., Apr. 30, 4:14 AM
Recent mergers and acquisitions in the Medical Instruments & Supplies M&A category.
Slide #35. AtriCure — Estech
Acquirer: |
AtriCure (NASDAQ:ATRC) |
Acquiree: |
Estech |
Details: |
AtriCure, Inc. (NASDAQ:ATRC), a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/b/a Estech ("Estech"). Estech develops and markets a portfolio of innovative surgical ablation devices that enable physicians to perform a variety of traditional and minimally invasive procedures using Estech's proprietary temperature controlled RF energy. |
AtriCure provides treatments for atrial fibrillation (Afib), left atrial appendage management and post-operative pain. Co.'s ablation and left atrial appendage management products are used by physicians during both open-heart and minimally invasive procedures. Co.'s Isolator® Synergy Ablation System is approved by U.S. Food and Drug Administration (FDA) for the treatment of persistent and long-standing persistent Afib concomitant to other open-heart surgical procedures. The EPi-Sense® system is approved by FDA to treat patients with long-standing persistent Afib. All of Co.'s other ablation devices are cleared for sale in U.S., including its other radio frequency and cryoablation products.
ATRC SEC Filing Email Alerts Service
Open the ATRC Page at The Online Investor »
Company Name: |
AtriCure Inc |
Website: |
www.atricure.com |
Sector: |
Medical Instruments & Supplies |
Number of ETFs Holding ATRC: |
29 |
Total Market Value Held by ETFs: |
$153.31M |
Total Market Capitalization: |
$1.07B |
% of Market Cap. Held by ETFs: |
14.30% |
|
Open the ATRC Page at The Online Investor (in a new window) »
|
April 30, 2024 4:14 AM Eastern
Strong Buy (3.89 out of 4)
75th percentile
|
|